These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31028405)

  • 21. Functional MRI detects perfusion impairment in renal allografts with delayed graft function.
    Hueper K; Gueler F; Bräsen JH; Gutberlet M; Jang MS; Lehner F; Richter N; Hanke N; Peperhove M; Martirosian P; Tewes S; Vo Chieu VD; Großhennig A; Haller H; Wacker F; Gwinner W; Hartung D
    Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1444-51. PubMed ID: 25925250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over 5 Years of Excellent Graft Kidney Function Determinants: Baskent University Experience.
    Sayin B; Ozdemir A; Ayvazoglu Soy EH; Kirnap M; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):75-77. PubMed ID: 30777527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired kidney allograft: how long can it function? A single-center study of the transplantation population.
    Magott-Procelewska M; Boratyńska M; Madziarska K; Chudoba P; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2692-5. PubMed ID: 25380896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation.
    Cippà PE; Liu J; Sun B; Kumar S; Naesens M; McMahon AP
    Nat Commun; 2019 Mar; 10(1):1157. PubMed ID: 30858375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emphysematous pyelonephritis in renal allograft related to antibody-mediated rejection: A case report and literature review.
    Takahashi K; Malinzak LE; Safwan M; Kim DY; Patel AK; Denny JE
    Transpl Infect Dis; 2019 Feb; 21(1):e13026. PubMed ID: 30414224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
    Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
    J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement activation in renal allograft recipients.
    Kirschfink M; Wienert T; Rother K; Pomer S
    Transplant Proc; 1992 Dec; 24(6):2556-7. PubMed ID: 1465864
    [No Abstract]   [Full Text] [Related]  

  • 29. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.
    Potluri VS; Parikh CR; Hall IE; Ficek J; Doshi MD; Butrymowicz I; Weng FL; Schröppel B; Thiessen-Philbrook H; Reese PP
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):324-31. PubMed ID: 26668026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.
    Okushi Y; Okino K; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Oct; 21(5):932-940. PubMed ID: 28364323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity.
    Sánchez-Zapardiel E; Castro-Panete MJ; Mancebo E; Morales P; Laguna-Goya R; Morales JM; Apaza J; de Andrés A; Talayero P; Paz-Artal E
    Nephrol Dial Transplant; 2016 Jan; 31(1):150-60. PubMed ID: 26323481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.
    Viglietti D; Bouatou Y; Kheav VD; Aubert O; Suberbielle-Boissel C; Glotz D; Legendre C; Taupin JL; Zeevi A; Loupy A; Lefaucheur C
    Kidney Int; 2018 Oct; 94(4):773-787. PubMed ID: 29801667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies.
    Legendre C
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):59-60. PubMed ID: 25546763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.